US 12,290,695 B2
Neural stimulation devices and systems for treatment of chronic inflammation
Michael A. Faltys, Valencia, CA (US); Jesse M. Simon, Los Angeles, CA (US); and Yiming Liu, Woburn, MA (US)
Assigned to SetPoint Medical Corporation, Valencia, CA (US)
Filed by SetPoint Medical Corporation, Valencia, CA (US)
Filed on Jul. 28, 2021, as Appl. No. 17/443,875.
Application 16/005,191 is a division of application No. 14/887,192, filed on Oct. 19, 2015, granted, now 9,993,651, issued on Feb. 11, 2016.
Application 14/082,047 is a division of application No. 12/978,250, filed on Dec. 23, 2010, granted, now 8,612,002, issued on Dec. 17, 2013.
Application 17/443,875 is a continuation of application No. 16/544,882, filed on Aug. 19, 2019, granted, now 11,110,287.
Application 16/544,882 is a continuation of application No. 16/005,191, filed on Jun. 11, 2018, granted, now 10,384,068, issued on Aug. 20, 2019.
Application 14/887,192 is a continuation of application No. 14/508,940, filed on Oct. 7, 2014, granted, now 9,162,064, issued on Oct. 20, 2015.
Application 14/508,940 is a continuation of application No. 14/082,047, filed on Nov. 15, 2013, granted, now 8,855,767, issued on Oct. 7, 2014.
Claims priority of provisional application 61/306,849, filed on Feb. 22, 2010.
Claims priority of provisional application 61/289,946, filed on Dec. 23, 2009.
Prior Publication US 2021/0353949 A1, Nov. 18, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/372 (2006.01); A61N 1/375 (2006.01); A61N 1/378 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/3787 (2013.01) [A61N 1/36053 (2013.01); A61N 1/3606 (2013.01); A61N 1/36125 (2013.01); A61N 1/36142 (2013.01); A61N 1/37205 (2013.01); A61N 1/37235 (2013.01); A61N 1/375 (2013.01); A61N 1/3756 (2013.01); A61N 1/0556 (2013.01); A61N 1/36175 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A leadless, implantable microstimulator device, the device comprising:
a hermetically sealed capsule body;
an electrode saddle on a first side of the capsule body, wherein the electrode saddle comprises an electrode saddle body having a first concave region and a second concave region, wherein the first concave region is separated along the length of the hermetically sealed capsule body by a non-concave gap region from the second concave region, wherein a first electrode is molded into the first concave region and a second electrode is molded into the second concave region; and
an electronic assembly within the sealed capsule body;
wherein the electronic assembly comprises a microcontroller configured to control the application of electrical energy to a nerve held against the electrode saddle by applying energy between the first electrode and the second electrode.